泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TTNP 泰坦制药

交易中 11-22 14:18:22 EST

3.65

-0.16

-4.20%

最高3.93	最低3.57	成交量5,824
今开3.57	昨收3.81	日振幅9.45%
总市值333.70万	流通市值255.52万	总股本91.42万
成交额2.16万	换手率0.83%	流通股本70.01万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TTNP","market":"US","secType":"STK","nameCN":"泰坦制药","latestPrice":3.65,"timestamp":1732302901178,"preClose":3.81,"halted":0,"volume":5824,"delay":0,"floatShares":700056,"shares":914234,"eps":-6.67196,"marketStatus":"交易中","marketStatusCode":2,"change":-0.16,"latestTime":"11-22 14:18:22 EST","open":3.57,"high":3.9299,"low":3.57,"amount":21558.054335999997,"amplitude":0.094462,"askPrice":3.93,"askSize":100,"bidPrice":3.6,"bidSize":396,"shortable":3,"etf":0,"ttmEps":-6.67196,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"adjPreClose":3.81,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.93,"preClose":3.93,"latestTime":"16:42 EST","volume":2,"amount":7.44,"timestamp":1732225367480},"volumeRatio":0.39052,"impliedVol":2.3693,"impliedVolPercentile":0.9714},"requestUrl":"/m/hq/s/TTNP","defaultTab":"news","newsList":[{"id":"2485269701","title":"泰坦制药盘中异动 急速下跌9.16%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485269701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485269701?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:32","pubTimestamp":1732285920,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时32分，泰坦制药股票出现异动，股价快速跳水9.16%。截至发稿，该股报3.57美元/股，成交量695股，换手率0.08%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.37%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223200a24e207a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223200a24e207a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2485793412","title":"泰坦制药盘中异动 大幅拉升7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485793412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485793412?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:48","pubTimestamp":1732207717,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时48分，泰坦制药股票出现波动，股价大幅拉升7.95%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.03%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122004837a24bb188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122004837a24bb188&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2485147818","title":"泰坦制药盘中异动 临近午盘股价大涨6.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485147818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485147818?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:54","pubTimestamp":1732121691,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时54分，泰坦制药股票出现异动，股价急速拉升6.72%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.66%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121005451971a7bbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121005451971a7bbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2483383165","title":"泰坦制药盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483383165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483383165?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:49","pubTimestamp":1731599360,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时49分，泰坦制药股票出现异动，股价快速下跌5.06%。截至发稿，该股报3.94美元/股，成交量6822股，换手率0.75%，振幅3.61%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.49%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234920a237facf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234920a237facf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2483884463","title":"泰坦制药盘中异动 股价大涨5.54%报4.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884463","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884463?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:53","pubTimestamp":1731509590,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时53分，泰坦制药股票出现波动，股价大幅拉升5.54%。截至发稿，该股报4.66美元/股，成交量198股，换手率0.02%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.39%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225310abbde7fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225310abbde7fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2480458276","title":"泰坦制药盘中异动 股价大跌5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480458276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480458276?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:56","pubTimestamp":1730732214,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时56分，泰坦制药股票出现波动，股价快速下挫5.72%。截至发稿，该股报3.78美元/股，成交量386股，换手率0.04%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.08%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225654ab9eca86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225654ab9eca86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2480051508","title":"泰坦制药盘中异动 股价大跌6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480051508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480051508?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:12","pubTimestamp":1730394770,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日01时12分，泰坦制药股票出现异动，股价大幅跳水6.17%。截至发稿，该股报3.80美元/股，成交量1971股，换手率0.22%，振幅2.38%。泰坦制药股票所在的生物技术行业中，整体跌幅为3.50%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101011250971a39c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101011250971a39c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2479286647","title":"泰坦制药盘中异动 早盘股价大涨7.09%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479286647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479286647?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:09","pubTimestamp":1730210964,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日22时09分，泰坦制药股票出现波动，股价急速上涨7.09%。截至发稿，该股报4.09美元/股，成交量1215股，换手率0.13%，振幅4.99%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.40%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102922092498e3f1fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102922092498e3f1fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2478228481","title":"泰坦制药盘中异动 早盘快速跳水7.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478228481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478228481?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:07","pubTimestamp":1730124422,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时07分，泰坦制药股票出现异动，股价急速下挫7.50%。截至发稿，该股报3.57美元/股，成交量445股，换手率0.05%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.46%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822070295bd75f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822070295bd75f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2478995696","title":"泰坦制药盘中异动 股价大跌5.34%报3.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478995696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478995696?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:38","pubTimestamp":1729874281,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时38分，泰坦制药股票出现异动，股价急速下挫5.34%。截至发稿，该股报3.75美元/股，成交量3416股，换手率0.37%，振幅2.52%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.80%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026003801ab74629d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026003801ab74629d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2478654523","title":"BUZZ-泰坦制药因首席执行官宣布辞职而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2478654523","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478654523?lang=zh_cn&edition=full","pubTime":"2024-10-25 00:13","pubTimestamp":1729786389,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月24日 - ** 专业制药公司泰坦制药  股价下跌5%，报4美元** Seow Gim Shen将辞去公司首席执行官兼董事长职务 ** 因个人原因决定辞职 ** 公司称辞职不会影响之前宣布的与KE Sdn. Bhd的业务合并 (link) ** 公司开始寻找新的首席执行官 ** 股价今年以来下跌 ~50.52","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2477554576","title":"泰坦制药盘中异动 早盘大幅下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477554576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477554576?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:16","pubTimestamp":1729782984,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日23时16分，泰坦制药股票出现波动，股价急速下挫5.07%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.10%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024231625ab70dded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024231625ab70dded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2477534646","title":"泰坦制药盘中异动 早盘股价大涨7.83%报4.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477534646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477534646?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:47","pubTimestamp":1729694842,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时47分，泰坦制药股票出现异动，股价急速拉升7.83%。截至发稿，该股报4.67美元/股，成交量2084股，换手率0.23%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体跌幅为1.00%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023224723a1e42973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023224723a1e42973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2477089550","title":"泰坦制药盘中异动 大幅跳水5.85%报4.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477089550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477089550?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:20","pubTimestamp":1729527635,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时20分，泰坦制药股票出现波动，股价急速下跌5.85%。截至发稿，该股报4.51美元/股，成交量398股，换手率0.04%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.57%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022002036ab6bc279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022002036ab6bc279&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2476942876","title":"泰坦制药盘中异动 急速上涨5.32%报4.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476942876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476942876?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:50","pubTimestamp":1729097429,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时50分，泰坦制药股票出现异动，股价急速上涨5.32%。截至发稿，该股报4.95美元/股，成交量5417股，换手率0.59%，振幅8.30%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.41%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017005030a1e1256f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017005030a1e1256f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2474229642","title":"泰坦制药盘中异动 早盘股价大跌5.10%报4.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474229642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474229642?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:53","pubTimestamp":1728482027,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时53分，泰坦制药股票出现异动，股价大幅下跌5.10%。截至发稿，该股报4.84美元/股，成交量372股，换手率0.04%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.52%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009215348a1df6bfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009215348a1df6bfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2473102756","title":"泰坦制药盘中异动 早盘股价大跌5.28%报5.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473102756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473102756?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:02","pubTimestamp":1728313321,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时02分，泰坦制药股票出现异动，股价急速跳水5.28%。截至发稿，该股报5.02美元/股，成交量2458股，换手率0.27%，振幅1.13%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.38%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072302019595e37f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072302019595e37f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2472652458","title":"泰坦制药盘中异动 股价大涨5.40%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472652458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472652458?lang=zh_cn&edition=full","pubTime":"2024-10-02 22:29","pubTimestamp":1727879388,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日22时29分，泰坦制药股票出现波动，股价急速拉升5.40%。截至发稿，该股报5.49美元/股，成交量2314股，换手率0.25%，振幅3.07%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.91%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002222948ab6776f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002222948ab6776f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2472332095","title":"泰坦制药盘中异动 股价大跌6.02%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472332095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472332095?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:45","pubTimestamp":1727718329,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时45分，泰坦制药股票出现波动，股价大幅下挫6.02%。截至发稿，该股报5.15美元/股，成交量9482股，换手率1.04%，振幅4.71%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.58%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001014529ab67300a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001014529ab67300a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2470737236","title":"泰坦制药盘中异动 早盘股价大涨6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470737236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470737236?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:59","pubTimestamp":1727359146,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时59分，泰坦制药股票出现波动，股价大幅上涨6.36%。截至发稿，该股报5.52美元/股，成交量5846股，换手率0.64%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.04%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262159069719cd7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262159069719cd7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.titanpharm.com","stockEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0924},{"period":"3month","weight":-0.3589},{"period":"6month","weight":-0.3876},{"period":"1year","weight":-0.4721},{"period":"ytd","weight":-0.5236}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Titan Pharmaceuticals, Inc.于1992年2月根据特拉华州法律成立。该公司是一家制药公司，利用专有的长期给药平台ProNeura开发治疗方法，用于治疗特定的慢性疾病，稳态给药有可能带来疗效或安全益处。ProNeura由一种小型固体植入物组成，由乙烯-醋酸乙烯酯或EVA和一种药物混合而成。产生的产物是一种固体基质，其设计目的是在一个简短的门诊程序中进行皮下给药，并在治疗期结束时以类似的方式去除。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.012139},{"month":2,"riseRate":0.555556,"avgChangeRate":0.039371},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.022961},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.054959},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.079034},{"month":6,"riseRate":0.555556,"avgChangeRate":0.008509},{"month":7,"riseRate":0.222222,"avgChangeRate":0.086632},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.134895},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.189655},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.05513},{"month":11,"riseRate":0.3,"avgChangeRate":-0.060717},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.092274}],"exchange":"NASDAQ","name":"泰坦制药","nameEN":"Titan Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰坦制药(TTNP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰坦制药,TTNP,泰坦制药股票,泰坦制药股票老虎,泰坦制药股票老虎国际,泰坦制药行情,泰坦制药股票行情,泰坦制药股价,泰坦制药股市,泰坦制药股票价格,泰坦制药股票交易,泰坦制药股票购买,泰坦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰坦制药(TTNP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}